Teligent, Inc. Announces Health Canada Approval Of Three Baclofen Injection Products

BUENA, N.J., Aug. 25, 2016 -- (Healthcare Sales & Marketing Network) -- Teligent, Inc. (TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that its Estonian subsidiary, Teligent OÜ, has received three Abbreviated New ... Biopharmaceuticals, Generics, Regulatory Teligent, Baclofen
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news